Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memory.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-85919-x
- By:
- Publication type:
- Article
Works matching AU Prehn, Christian
Results: 7
1
2
Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 8, p. 5525, doi. 10.1007/s00415-024-12511-0
- By:
- Publication type:
- Article
3
Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 2, p. 365, doi. 10.1007/s00415-014-7566-6
- By:
- Publication type:
- Article
4
Course of neuropsychological impairment during natalizumab‐associated progressive multifocal leukoencephalopathy.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 3, p. 921, doi. 10.1111/ene.14604
- By:
- Publication type:
- Article
5
Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2<sup>*</sup> Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla.
- Published in:
- Frontiers in Neurology, 2019, v. 10, p. 1, doi. 10.3389/fneur.2019.01320
- By:
- Publication type:
- Article
6
Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130352
- By:
- Publication type:
- Article
7
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
- Published in:
- CNS Neuroscience & Therapeutics, 2016, v. 22, n. 12, p. 1019, doi. 10.1111/cns.12652
- By:
- Publication type:
- Article